2Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
3Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
4Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
5Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
6Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
7Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia[J].N Engl J Med,1997,336:243-250.
8Skerrett SJ.Diagnostic testing for community-acquired pneumonia[J].Clin Chest Med,1999,20:531-548.
9Dean NC,Silver MP,Bateman KA,et al.Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia[J].Am J Med,2001,110:451-457.
10Niederman MS.Guidelines for the management of community-acquired pneumonia[J].Med Clin North Am,2001,85:1493-1501.
